The hospital chain’s stock price traded as low as $2.93 on Oct. 2 after closing Oct. 1 at $3.21 per share. Over the past year, CHS shares have traded between $2.66 and $7.86.
CHS saw its net loss shrink in the second quarter of 2018 as the company continued to refine its hospital portfolio. The company is using proceeds from the hospital divestitures to pay down its debt load.
More articles on healthcare finance:
Nurses call for Michigan hospital CEO to step down as possibility of bankruptcy looms
Cleveland Clinic agrees to invest $250M in Florida hospital
Dignity Health’s net income more than doubles
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
